STAT

Columbia’s dismissal of prominent neuroscientist prompts demand for answers

Columbia University students and postdoctoral fellows are urging administrators to specify why they closed a prominent neuroscientist's lab and ended his administrative positions.
Neuroscientist Thomas Jessell

Dozens of current and former students and postdoctoral fellows at Columbia University are urging administrators to specify why the school announced last week that it would close the lab of prominent neuroscientist Thomas Jessell and end his administrative positions.

Columbia has declined to offer any explanation for Jessell’s removal beyond a terse statement that said an investigation had “revealed serious violations of University policies and values governing the behavior of faculty members in an academic environment.” That statement, current and former students say in an , has

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks